Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations

• Chunxia Su,
• Shi-Yong Sun

Affiliations

Chunxia Su

Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China

Shi-Yong Sun

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, United States